We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
+4.96%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$143M
AUM Growth
+$22.1M
(+18%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
11.27%
Top 10 Holdings %
Top 10 Hldgs %
29.03%
Holding
133
New
20
Increased
32
Reduced
10
Closed
2
Top Buys
| 1 |
Nucor
NUE
|
+$1.84M |
| 2 |
Pfizer
PFE
|
+$1.28M |
| 3 |
GLOP
GASLOG PARTNERS LP
GLOP
|
+$1.14M |
| 4 |
American Express
AXP
|
+$1.02M |
| 5 |
GE Aerospace
GE
|
+$786K |
Top Sells
| 1 |
Sempra
SRE
|
+$302K |
| 2 |
Target
TGT
|
+$232K |
| 3 |
APC
Anadarko Petroleum
APC
|
+$130K |
| 4 |
Palo Alto Networks
PANW
|
+$67.1K |
| 5 |
Diageo
DEO
|
+$56.1K |
Sector Composition
| 1 | Healthcare | 23.33% |
| 2 | Energy | 13.82% |
| 3 | Industrials | 12.78% |
| 4 | Technology | 10.99% |
| 5 | Financials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MMP
26
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.7M | 1.19% |
22,130
| – | – |
|
27
PepsiCo
PEP
$187B
| $1.68M | 1.18% |
15,012
+250
| +2% | +$26.8K |
|
28
Procter & Gamble
PG
$349B
| $1.66M | 1.16% |
18,484
| – | – |
|
29
Merck
MRK
$315B
| $1.66M | 1.16% |
27,349
| – | – |
|
30
Stanley Black & Decker
SWK
$14B
| $1.64M | 1.15% |
12,350
| – | – |
|
31
Baxter International
BAX
$11.7B
| $1.64M | 1.15% |
31,600
| – | – |
|
32
Revvity
RVTY
$12.3B
| $1.61M | 1.13% |
27,800
| – | – |
|
|
33
Diageo
DEO
$46.7B
| $1.57M | 1.1% |
13,600
-500
| -4% | -$56.1K |
|
34
Northrop Grumman
NOC
$74.1B
| $1.52M | 1.07% |
6,388
| – | – |
|
35
Assured Guaranty
AGO
$3.76B
| $1.48M | 1.04% |
39,800
-500
| -1% | -$19.8K |
|
|
HES
36
DELISTED
Hess
HES
| $1.45M | 1.02% |
30,150
+12,141
| +67% | +$643K |
|
|
SHPG
37
DELISTED
Shire pic
SHPG
| $1.45M | 1.02% |
8,310
+1,932
| +30% | +$337K |
|
38
Automatic Data Processing
ADP
$102B
| $1.43M | 1% |
14,000
+150
| +1% | +$15.3K |
|
|
DD
39
DELISTED
Du Pont De Nemours E I
DD
| $1.37M | 0.96% |
17,028
| – | – |
|
40
Sanofi
SNY
$107B
| $1.3M | 0.91% |
28,700
| – | – |
|
41
Colgate-Palmolive
CL
$74.4B
| $1.24M | 0.87% |
17,000
| – | – |
|
|
GLOP
42
DELISTED
GASLOG PARTNERS LP
GLOP
| $1.21M | 0.85% |
+49,400
| New | +$1.14M |
|
43
AstraZeneca
AZN
$262B
| $1.16M | 0.81% |
18,588
| – | – |
|
44
Berkshire Hathaway Class B
BRK.B
$1.06T
| $1.14M | 0.8% |
6,854
| – | – |
|
45
Qualcomm
QCOM
$181B
| $1.14M | 0.8% |
19,875
+11,843
| +147% | +$687K |
|
46
Caterpillar
CAT
$405B
| $1.08M | 0.76% |
11,641
| – | – |
|
47
AbbVie
ABBV
$450B
| $1.03M | 0.72% |
15,843
+2,900
| +22% | +$182K |
|
48
NETSCOUT
NTCT
$2.95B
| $1.03M | 0.72% |
27,150
| – | – |
|
|
49
Palo Alto Networks
PANW
$292B
| $1M | 0.7% |
53,400
-3,000
| -5% | -$67.1K |
|
50
Fresenius Medical Care
FMS
$13B
| $981K | 0.69% |
23,288
| – | – |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q1 2017 Portfolio in Review
As of Q1 2017, Searle & Co held 133 positions worth $143M, up 18% from $121M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Searle & Co deployed $16.1M of net new capital in Q1 2017, opening 20 new positions and adding to 32 existing holdings. Its largest new stake was Nucor: 30,050 shares worth $1.79M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was Anadarko Petroleum, an estimated $130K trimmed.
- Searle & Co's largest Q1 2017 buy was Nucor: 30,050 shares worth $1.79M.
- Searle & Co added most to Pfizer in Q1 2017, an estimated $1.28M increase.
- Searle & Co's biggest Q1 2017 reduction was Anadarko Petroleum, cutting an estimated $130K.
- Searle & Co fully exited Sempra in Q1 2017, selling an estimated $302K.
- Searle & Co's ten largest holdings make up 29% of its $143M portfolio in Q1 2017.
- Searle & Co opened 20 new positions and closed 2 in Q1 2017.
- Searle & Co's portfolio value rose 18% quarter-over-quarter to $143M.
Based on Searle & Co's 13F filing for Q1 2017, filed 2 May 2017.